Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
ImmunityBio, Inc. (NK) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/28/2023 DEF 14C Form DEF 14C - Other definitive information statements:
08/15/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/25/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/24/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/21/2023 8-K Quarterly results
07/20/2023 8-K Quarterly results
05/22/2023 SC 13D/A Cambridge Equities, LP reports a 77.3% stake in ImmunityBio, Inc.
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/31/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "IMMUNITYBIO, INC. CONVERTIBLE PROMISSORY NOTE"
03/20/2023 8-K Quarterly results
02/14/2023 8-K Results of Operations and Financial Condition  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/13/2023 8-K Quarterly results
02/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
12/12/2022 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obl...
Docs: "Placement Agency Agreement by and between the Company and Piper Sandler & Co.",
"Form of Common Stock Purchase Warrant",
"Legal Opinion of Wilson Sonsini Goodrich & Rosati, P.C",
"Securities Purchase Agreement",
"Promissory Note between the Company and Nant Capital, LLC",
"ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor"
12/12/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/12/2022 S-3MEF Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
12/12/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/06/2022 SC 13D/A Cambridge Equities, LP reports a 80.9% stake in ImmunityBio, Inc.
12/05/2022 8-K Quarterly results
11/15/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
09/02/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/22/2022 D Form D - Notice of Exempt Offering of Securities:
06/14/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/14/2022 8-K Quarterly results
05/26/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/17/2022 POS EX Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
05/17/2022 AW Form AW - Amendment Withdrawal Request:
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy